ALLIX

Serial Number 97600646
606

Registration Progress

Application Filed
Sep 21, 2022
Under Examination
Jul 25, 2023
Approved for Publication
May 30, 2023
Published for Opposition
May 30, 2023
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ALLIX
Previous Owner: Clairity, Inc.
Classes: 042, 044

Trademark Image

ALLIX

Basic Information

Serial Number
97600646
Filing Date
September 21, 2022
Published for Opposition
May 30, 2023
Abandonment Date
August 25, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 25, 2025
Classes
042 044

Rights Holder

Clairity, Inc.

03
Address
201 W 5th Street, Suite 1500
Austin, TX 78701

Ownership History

Clairity, Inc.

Original Applicant
03
Austin, TX

Clairity, Inc.

Owner at Publication
03
Austin, TX

Legal Representation

Attorney
Omar M. Wadhwa

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

35 events
Date Code Type Description Documents
Aug 25, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 25, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 12, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 12, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 12, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 24, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 23, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 23, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 23, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 18, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 18, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 18, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 11, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 11, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 25, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 30, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 30, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 10, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 24, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 24, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 24, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 24, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 24, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 20, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 19, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 19, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 19, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 19, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 19, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 18, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 6, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 24, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific and technological services, namely, scientific analysis of medical data and medical imaging in the field of breast health, including by means of artificial intelligence and deep learning in the fields of genomics, proteomics and radiomics
Class 044
Medical analysis services relating to the treatment of persons; providing information, advice, and data on medical imaging relating to breast health; medical analysis of medical data and medical imaging in the field of breast health, including by means of artificial intelligence and deep learning in the fields of genomics, proteomics and radiomics; consulting services in the field of medicine, namely, the assessment and prediction of breast health risks, patient engagement in the nature of diagnosis and treatment, consultations relating to predicted clinical outcomes

Classification

International Classes
042 044